Gitelman syndrome is an inherited kidney disease. Gitelman syndrome is caused by a defect in the kidney’s ability to reabsorb magnesium, sodium, potassium, and chloride also known as electrolytes. This is due to a mutation in the gene that codes for one of the electrolyte transporters in the kidney. The absence of this transporter may account for loss of magnesium and potassium and inadequate excretion of calcium from the kidneys. It is estimated that Gitelman syndrome occurs in 1 in 40,000 individuals. It affects both males and females of all ethnic backgrounds. Some of the symptoms include weakness and fatigue, muscle cramping excessive urination, and salt cravings.
Gitelman Syndrome Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Gitelman Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 568 products for the study of Gitelman Syndrome that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Gitelman Syndrome is also known as gitelman syndrome, hypomagnesemia-hypokalemia, primary renotubular, with hypocalciuria, hypokalemia-hypomagnesemia, primary renotubular, with hypocalciuria, tubular hypomagnesemia-hypokalemia with hypocalcuria, familial hypokalemia-hypomagnesemia, potassium and magnesium depletion, renal tubular disorder, gs.